Teenage cancer patients will die because of trial age limits which prevent them from testing new drugs. Teenage Cancer Trust report found that young people are missing out on chance to take part in clinical trials. They also often suffer from rare cancers which pharmaceutical companies are unwilling to invest in because finding a drug for such a small number of people would not be profitable.